Skip to main content
OpenTrials

Clinical trial condition

Stage IV Uveal Melanoma AJCC v7

Explore clinical trials studying Stage IV Uveal Melanoma AJCC v7. Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IV Uveal Melanoma AJCC v7 trial results

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

NCT01989572

Conditions
Eye Diseases, Eye Neoplasms, Iris Melanoma, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 148 locations
View Trial Details
Completed

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

NCT01835145

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 228 locations
View Trial Details
Completed

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

NCT02363283

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 25 locations
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

NCT02158520

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +19 more
Locations
  • Saint Mary's Medical Center San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Illinois Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

NCT01979523

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Active, Not Recruiting

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

NCT01587352

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details

Related conditions